The 2027 lineup drops to the Insider List first — get on it

Democrats Flipped Nine Senate Seats. Here's What It Means for Legal Weed.

Alaska made it nine. Federal legalization looks possible again, but banking and hemp come first.

NY 420 Week cover: Democrats flipped nine Senate seats.
NY 420 Week cover: Democrats flipped nine Senate seats.

The map nobody saw coming

Early in the cycle, the people who handicap elections gave Democrats well under a 50-50 shot at the Senate (The Hill). Republicans went into Election Night with a 53-47 majority and a map that was supposed to protect it. By the time the counting slowed down, Democrats had flipped seven Senate seats: North Carolina, South Carolina, Ohio, Texas, Kansas, Iowa and Maine (NPR). Eight days later Mississippi made it eight, when Sen. Cindy Hyde-Smith conceded to Democrat Scott Colom (The Hill).

9
Senate seats flipped to Democrats
44
House seats flipped to Democrats
6
Governor's offices flipped to Democrats
Source: NPR, The Hill, CBS News, MultiState (as of Nov 18, 2026)

Alaska made it nine. On Tuesday night, November 17, the Associated Press called the last uncalled Senate race of the year for former Rep. Mary Peltola over Republican Sen. Dan Sullivan (NPR). The latest count had her at 144,302 votes to his 131,844, or 50.12%, which put her over the 50% line and meant Alaska didn't need its ranked-choice count (Alaska's News Source). It's a seat in a state Trump carried in each of the last three presidential elections.

That's nine Senate seats Democrats took from Republicans in a single election. Several of the new senators come from states with no legal adult-use sales, like Mississippi, Texas and both Carolinas, and they'll have to decide where they stand on federal cannabis.

The House went the same direction. CBS counts 44 districts that flipped from Republican to Democrat, with three going the other way (CBS News). Democrats also flipped six governor's offices (Alaska, Georgia, Iowa, Nevada, Ohio and Texas), and Republicans didn't flip a single one (MultiState).

For anybody who works in cannabis, the question is simple. Does this finally get weed out of the Controlled Substances Act?

The honest answer is that the odds just got a lot better, but the first wins are going to be smaller than legalization.

Where federal weed policy actually stands

You need to know where things stand right now, because the last year has been messy.

In April, the Justice Department moved part of the plant to Schedule III. Following President Trump's December 2025 executive order, Acting Attorney General Todd Blanche signed an order covering two things: FDA-approved drugs made from marijuana, and marijuana sold under a state medical license. The rule was published in the Federal Register and took effect April 28 (Federal Register). For medical operators that's real money, because the 280E tax penalty only hits Schedule I and II businesses (Cannabis Law Report).

Adult-use weed is still Schedule I. The rule didn't legalize anything or open up interstate commerce, and it's being challenged in the D.C. Circuit by prohibition groups and the attorneys general of Nebraska and Indiana (Cannabis Business Times).

The bigger move, putting all marijuana in Schedule III, is still sitting with a DEA judge. Chief Administrative Law Judge Derek Julius heard 11 days of testimony this summer (Morgan Lewis). Then opponents got the case paused in September over a GAO report on how federal agencies schedule drugs. In October, Julius refused to reopen the hearing but let the report into the record (Marijuana Moment). The final briefs were filed November 5. As of this weekend he still hasn't issued his recommendation, and there's no date for it (Ganjly).

Even when he does, it's only a recommendation. The DEA administrator makes the final call, and whoever loses can appeal. And Schedule III still isn't legal weed.

Why Congress is the part that matters

Rescheduling is the executive branch tinkering with a list. Actually ending prohibition takes Congress, and until two weeks ago Congress wasn't going anywhere near it.

The main legalization bill is the Cannabis Administration and Opportunity Act, or CAOA. Sens. Cory Booker, Chuck Schumer and Ron Wyden reintroduced it on July 16, with more than a dozen other Democrats signed on as original cosponsors (NORML). It would pull cannabis off the federal drug schedules entirely, end 280E and add a federal excise tax. The 2026 version also includes language to stop the hemp ban.

When it was reintroduced, nobody expected a vote. The Marijuana Policy Project said it was unlikely to pass this Congress, but that if Democrats retook the Senate it would likely be the main legalization vehicle in the next one (MPP). That's exactly what happened. Schumer is expected to become Majority Leader when Senate Democrats pick their leaders in early December (The Hill).

The House history points the same way. The MORE Act, which would also deschedule marijuana, passed the House in 2020 and 2022, both times under Democratic control. SAFE Banking has passed the House seven times (NORML).

There's even some bipartisan noise. Rep. Dina Titus, who co-chairs the Congressional Cannabis Caucus, and longtime GOP operative Roger Stone both told Marijuana Moment there's room to work together on federal reform after the midterms (Marijuana Moment).

What's still in the way

I want to be careful here, because this industry has been burned by "next year" too many times.

The filibuster is still there. Descheduling needs 60 votes in the Senate. Even with nine new seats, Democrats don't have 60, and every original CAOA cosponsor is a Democrat. The bill needs Republican votes it doesn't have yet.

The President still has a veto. Trump backed rescheduling, but I haven't found him saying anything clear about full descheduling or the CAOA. Harris Sliwoski lists a veto as one of three real risks to passage, alongside the filibuster and the chance that Democrats just don't make weed a priority (Harris Sliwoski). Democrats ran on the cost of living, not on cannabis.

Timing matters too. The new Congress isn't sworn in until January. Through December, the lame-duck Congress is still the Republican one.

The fights that happen first

So what can actually move? Two things.

Banking. On November 9, 16 Democratic governors asked Congress to pass the SAFE Banking Act in the lame duck, so cannabis businesses "can bank like everyone else" (Cannabis Business Times). Banking has always been the reform with the most Republican support, so if anything passes before full legalization, this is it.

Hemp. This one has a hard deadline. The spending law that ended last year's shutdown capped hemp products at 0.4 milligrams of total THC per container. Congress pushed most of that back to December 11 in a stopgap bill Trump signed in September (Vicente LLP). Part of the ban already kicked in on November 12, when products made with synthetic cannabinoids like THC-O became federally illegal (Cannabis Business Times).

The lame-duck Congress came back on November 9 and has to deal with hemp and government funding before both run out on December 11 (Learn Brands). Rep. Morgan Griffith wants to put a hemp regulation bill into a reconciliation package, which only needs 51 Senate votes (Cannabis Business Times). On the other side, a coalition of conservative, religious and drug-control groups is lobbying to let the ban take effect on schedule (Bloomberg Government).

Whatever happens with hemp in the next three weeks is the first real test of whether this Congress regulates cannabinoids or bans them.

The states moved too

Federal law gets the headlines, but the state results might matter sooner. Democrats flipped the Pennsylvania Senate, the chamber that had blocked legalization for years. I covered that in The Last Holdout Falls. They also won the Wisconsin legislature and the North Carolina House. (NORML). In Massachusetts, voters rejected the attempt to repeal adult-use sales (NORML).

Every new legal state adds two senators with a reason to care about federal law.

What to watch

  • Early December: Senate Democrats elect their leaders.
  • December 11: The hemp ban and government funding both run out unless Congress acts.
  • January: The new Congress is sworn in.
  • No date yet: The DEA judge's recommendation on full Schedule III, and the D.C. Circuit ruling on the medical rule.

For the first time in years, the path to federal legalization runs through a Congress that's at least willing to talk about it. Expect banking and hemp first. Full legalization is going to take Republican votes and a President's signature, and neither one is there yet.

Sources

  1. NPR via KUT: Democrats win full control of Congress
  2. The Hill: Hyde-Smith concedes to Colom
  3. NPR: Peltola flips Alaska's Senate seat
  4. Alaska's News Source: AP calls it for Peltola
  5. CBS News: every House district that flipped
  6. MultiState: 2026 governor results
  7. Federal Register: Schedule III final rule
  8. Cannabis Law Report: what the Schedule III rule does
  9. Cannabis Business Times: three states challenge the Schedule III rule
  10. Morgan Lewis: after the DEA hearing
  11. Marijuana Moment: DEA judge won't reopen hearing
  12. Ganjly: final briefs in the rescheduling hearing
  13. NORML: CAOA reintroduced (Senate tag page)
  14. Cannabusiness.law: the CAOA is back
  15. MPP: CAOA gets a chance in the Senate
  16. The Hill: Democrats win Senate majority
  17. NORML: congressional shake-up
  18. NORML: midterm results and state reforms
  19. Marijuana Moment newsletter, Nov 6, 2026
  20. Harris Sliwoski: cannabis reform after the midterms
  21. Cannabis Business Times: 16 governors urge SAFE Banking
  22. Vicente LLP: hemp definition change delayed to Dec 11
  23. Cannabis Business Times: THC-O now federally prohibited
  24. Learn Brands: hemp THC ban timeline
  25. Cannabis Business Times: Griffith's lame-duck hemp plan
  26. Bloomberg Government: hemp lobbying fight returns

The Insider List

Don’t find out
after it happens.

The Insider List is where New York 420 Week drops first — the full lineup, invite-only events, partner offers and our best research, straight to your inbox.

  • First look at the 2027 lineup
  • Early access to limited-capacity events
  • The week’s essential reads in five minutes
  • Zero spam. Leave anytime in one click.

Free · 21+

Get on the list.

872 New Yorkers already get it.